共 20 条
- [1] Shime N(2011)De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients Infection 39 319-325
- [2] Satake S(2007)Infectious diseases of America and the society for healthcare epidemiology of American guidelines for developing an institutional program to enhance antimicrobial stewardship Clin Infect Dis 44 159-177
- [3] Fujita N(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America Clin Infect Dis 52 e56-e93
- [4] Dellit TH(2005)Risk factors for infections with multidrug-resistant Cancer 104 205-212
- [5] Owens RC(2011) in patients with cancer Chemotherapy 57 335-338
- [6] McGowan JE(2005)Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Clin Infect Dis 40 S246-S252
- [7] Freifeld AG(2009) at a comprehensive cancer center in the United States Clin Infect Dis 48 1-12
- [8] Bow EJ(undefined)Challenges in the treatment of infections caused by Gram-positive and Gram-negative bacteria in patients with cancer and neutropenia undefined undefined undefined-undefined
- [9] Sepkowitz KA(undefined)Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America undefined undefined undefined-undefined
- [10] Ohmagari N(undefined)undefined undefined undefined undefined-undefined